Pieris Pharmaceuticals CEO Stephen Yoder's 2018 pay jumps 110% to $2.6M
Pieris Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: June 18, 2019
Pieris Pharmaceuticals reported fiscal year 2018 executive compensation information on June 18, 2019.
In 2018, three executives at Pieris Pharmaceuticals received on average a compensation package of $1.5M, a 29% increase compared to previous year.
Average pay of disclosed executives at Pieris Pharmaceuticals
Stephen S. Yoder, Chief Executive Officer, received $2.6M in total, which increased by 110% compared to 2017. 71% of Yoder's compensation, or $1.9M, was in option awards. Yoder also received $213K in bonus, $500K in salary, as well as $42K in other compensation.
Louis A. Matis, Chief Development Officer, received a compensation package of $1.1M, which increased by 58% compared to previous year. 51% of the compensation package, or $574K, was in option awards.
Allan Reine, Chief Financial Officer, earned $871K in 2018, a 56% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on June 18, 2019.